Source-based drug interaction reference · English
Drug interactions in English: source-based medicine pair records — Page 197
How to use this directory
Each record describes a documented medicine pair and links to its source information. Coverage is selective. Missing records do not establish safe use, and these pages do not replace individual review by a qualified healthcare professional.
These records are for information and research. Do not start, stop or change medicines based on a web page. Product formulations, licensed uses and advice can differ by country.
Dolutegravir and Oxcarbazepine (Oxcarbazepine (Okskarbazepin)): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolutegravir and Phenytoin sodium (Epdantoin 100 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolutegravir and Rennie Çiğneme Tableti: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolutegravir and Rifampicin (Rifcap 300 mg Kapsül): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolutegravir and Rilpivirine: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolutegravir and Talcid Chewable Tablets (Hydrotalcite): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolutegravir and Tardyferon 80 mg Uzatılmış Salımlı Kaplı Tablet: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolutegravir and Tenofovir disoproxil fumarate: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dolven 100 mg/5 ml Pediatrik Şurup and Glipizide interaction
Source-based drug interaction information. Detailed information is available with page access.
Dolven 100 mg/5 ml Pediatrik Şurup and Ketoprofen interaction
Source-based drug interaction information. Detailed information is available with page access.
Dolven 100 mg/5 ml Pediatrik Şurup and Piroxicam interaction
Source-based drug interaction information. Detailed information is available with page access.
Dolven 100 mg/5 ml Pediatrik Şurup and Repaglinide interaction
Source-based drug interaction information. Detailed information is available with page access.
Dolven 100 mg/5 ml Pediatrik Şurup and Tenofovir alafenamide interaction
Source-based drug interaction information. Detailed information is available with page access.
Dolven 100 mg/5 ml Pediatrik Şurup and Vilazodone interaction
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Aspirin 500 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Brilinta 60 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Brilinta 90 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Clexane 0.4 ml: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Clexane 0.6 ml: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Clexane 0.8 ml: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Coraspin 100 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Coumadin 2 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Coumadin 5 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Ecopirin 100 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Eliquis 2.5 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Eliquis 5 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Lixiana 60 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Oksapar 4000 Anti-Xa IU/0.4 ml: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Plavix 75 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Plavix 300 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Pradaxa 110 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Pradaxa 150 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Xarelto 2.5 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Xarelto 10 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Xarelto 15 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Donanemab and Xarelto 20 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Apalutamide: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Ator 20 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Bosentan: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Dolutegravir: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Efavirenz: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Enzalutamide: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Epdantoin 100 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Glucophage 500 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Glucophage 850 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Glucophage 1000 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Guselkumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Lamivudine: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Lipitor 10 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Doravirine and Lipitor 20 mg: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.